Endocrine Abstracts

Introduction: Modern research studies reveal a negative impact of diabetes on cognitive function. Nonetheless, little is known about the risk factors that are involved in this disturbance. The present study aimed to examine the associations among cognitive/emotional functions and a number of metabolic factors associated with diabetes, in order to identify a possible link between cognitive decline and diabetes.Materials and methods: One hundred thirty fiv...

Background: Sulfonylureas (SUs) are known to increase fasting insulin levels in patients with Type 2 Diabetes (T2D) treated with these agents. Whether this increase is related to a greater risk of hypoglycemia has not yet been sufficiently elucidated.Methods: The study included 58 patients with T2D who had been on treatment with SUs, but not insulin, for more than 2 years. Confirmed hypoglycemic episodes during the past year were self-reported by the pat...

Introduction: The present study aimed to investigate whether women who developed gestational diabetes mellitus (GDM) comply with the guidelines for gestational weight gain (GWG) according to their pre-pregnancy Body Mass Index (BMI).Methods: A retrospective study was conducted involving 195 pregnant women with GDM, aged 25–45 years, attending an academic hospital outpatient clinic. These women were divided into three groups according to pre-pregnanc...

Introduction: Gestational Diabetes Mellitus (GDM) is a disorder of glucose tolerance which is diagnosed for the first time during pregnancy. Thyroid disease is common in women of reproductive age and during gestation; both diseases have an adverse impact on pregnancy outcomes. The aim of this study was to assess the clinical and ultrasonographic characteristics in women with co-existing GDM and thyroid disease.Material and methods: In total, 112 pregnant...

Background: Women with PCOS carry cardiovascular (CV) risk factors, which may account for the increased CV risk. Oral contraception therapy using ethinyl-estradiol & cyproterone acetate (EE-CA) is administrated to normalize menstrual cycles and reduce serum androgen levels in women with PCOS. The aim of this study was to assess the effect of EE-CA on endothelial function in young, non-obese PCOS women.Methods: We studied 13 non-obese (body mass index...